Man Group
PRCT icon

Man Group’s Procept Biorobotics PRCT Stock Holding History

Man Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.75M Sell
254,845
-36,987
-13% -$926K 0.01% 1068
2026
Q1 		$7.3M Buy
+291,832
New +$8.22M 0.01% 971
2025
Q3 		– Sell
-20,573
Closed -$1.19M – 2413
2025
Q2 		$1.19M Sell
20,573
-179,734
-90% -$10.2M ﹤0.01% 1581
2025
Q1 		$11.7M Sell
200,307
-55,445
-22% -$3.79M 0.03% 667
2024
Q4 		$20.6M Buy
255,752
+192,352
+303% +$16.4M 0.05% 417
2024
Q3 		$5.08M Buy
+63,400
New +$4.5M 0.01% 1020

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Man Group's PRCT Position: Q2 2026 in Review

Man Group reduced its Procept Biorobotics (PRCT) stake by 13% in Q2 2026, selling an estimated $926K and leaving 254,845 shares worth $5.75M. The position accounts for 0.01% of the portfolio, ranked #1068.

Man Group first reported a position in PRCT in Q3 2024 and has held it in 6 quarters since. The position peaked at $20.6M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Man Group held 254,845 shares of Procept Biorobotics worth $5.75M as of Q2 2026.
  • Man Group sold 36,987 Procept Biorobotics shares in Q2 2026, an estimated $926K.
  • Procept Biorobotics made up 0.01% of Man Group's portfolio in Q2 2026, its #1068 holding.
  • Man Group first reported a position in Procept Biorobotics in Q3 2024 and has held it in 6 quarters since.
  • Man Group's Procept Biorobotics position peaked at $20.6M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.